Nanoformulation Strategies: Emerging Innovations in Drug Delivery Systems

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 03 | Issue : 01 | Page :
    By

    Tejas Naik,

  • Sachin Datkhile,

  • Sayali Wagh,

  • Saniya Pathan,

  1. Student, Department of Pharmaceutics, Samarth Institute of Pharmacy, Belhe, Pune, Maharashtra, India
  2. Associate Professor, Department of Pharmaceutics, Samarth Institute of Pharmacy, Belhe, Pune, Maharashtra, India
  3. Student, Department of Pharmaceutics, Samarth Institute of Pharmacy, Belhe, Pune, Maharashtra, India
  4. Student, Department of Pharmaceutics, Samarth Institute of Pharmacy, Belhe, Pune, Maharashtra, India

Abstract

Nanotechnology is significantly advancing the pharmaceutical industry by introducing nanosystems that improve drug delivery, therapeutic efficacy, and patient outcomes. Various nanosystems-such as liposomes, dendrimers, polymeric nanoparticles, solid lipid nanoparticles, carbon nanotubes, and metallic nanoparticles-offer benefits like enhanced bioavailability, targeted delivery, improved stability, and reduced side effects. Innovative formulation strategies, including surface functionalization, particle size optimization, and use of biodegradable carriers, support controlled and sustained drug release. Additionally, production in non-aqueous media further enhances solubility and formulation efficiency. Despite these advancements, nano-formulations face challenges such as aggregation, manufacturing limitations, and regulatory compliance. Regulatory bodies like the FDA and EMA have established guidelines to ensure the safe development and application of nanomedicine. Looking ahead, nanotechnology play an important role in precision medicine, especially for treating cancer, neurological disorders, and infectious diseases. Moreover, its expanding applications in diagnostics and vaccine delivery underscore its importance in future of healthcare.

Keywords: Nanoformulations, Nanotechnology, Solubility enhancement, Therapeutic efficacy, Nanocarriers, Polymeric nanoparticles.

[This article belongs to International Journal of Toxins and Toxics ]

How to cite this article:
Tejas Naik, Sachin Datkhile, Sayali Wagh, Saniya Pathan. Nanoformulation Strategies: Emerging Innovations in Drug Delivery Systems. International Journal of Toxins and Toxics. 2026; 03(01):-.
How to cite this URL:
Tejas Naik, Sachin Datkhile, Sayali Wagh, Saniya Pathan. Nanoformulation Strategies: Emerging Innovations in Drug Delivery Systems. International Journal of Toxins and Toxics. 2026; 03(01):-. Available from: https://journals.stmjournals.com/ijtt/article=2026/view=236730


References

1. Singh AP, Biswas A, Shukla A, Maiti P. Targeted therapy in chronic diseases using
nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther. 2019;4(1).
2. D.F. E, C.G. T. The pinpoint promise of nanoparticle-based drug delivery and
molecular diagnosis. Biomol Eng. 2006;23(4):171–84. Available from:
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed7&NEWS=N&
AN=2006363798
3. Emerich DF, Thanos CG. Targeted nanoparticle-based drug delivery and diagnosis. J

Drug Target. 2007;15(3):163–83.
4. Kaur IP, Singh H. Nanostructured drug delivery for better management of tuberculosis.
J Control Release. 2014;184(1):36–50.
5. Maruvada P, Wang W, Wagner PD, Srivastava S. Biomarkers in molecular medicine:
cancer detection and diagnosis. Biotechniques. 2005;Suppl:9–15.
6. Shukla T, Upmanyu N, Pandey SP, Sudheesh MS. Site-specific drug delivery,
targeting, and gene therapy. Nanoarchitectonics Biomed. 2019;473–505.
7. Mody V, Siwale R, Singh A, Mody H. Introduction to metallic nanoparticles. J Pharm
Bioallied Sci. 2010;2(4):282.
8. Alex S, Tiwari A. Functionalized gold nanoparticles: Synthesis, properties and
applications-A review. J Nanosci Nanotechnol. 2015;15(3):1869–94.
9. De Matteis V. Exposure to inorganic nanoparticles: Routes of entry, immune response,
biodistribution and in vitro/In vivo toxicity evaluation. Toxics. 2017;5(4).
10. Pochapski DJ, Carvalho Dos Santos C, Leite GW, Pulcinelli SH, Santilli CV. Zeta
Potential and Colloidal Stability Predictions for Inorganic Nanoparticle Dispersions:
Effects of Experimental Conditions and Electrokinetic Models on the Interpretation of
Results. Langmuir. 2021;37(45):13379–89.
11. Muro S. Challenges in design and characterization of ligand-targeted drug delivery
systems. J Control Release. 2012;164(2):125–37.
12. Wallace SJ, Li J, Nation RL, Boyd BJ. Drug release from nanomedicines: Selection of
appropriate encapsulation and release methodology. Drug Deliv Transl Res.
2012;2(4):284–92.
13. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on
cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials.
2010;31(13):3657–66.
14. Shah R, Eldridge D, Palombo E, Harding I. Optimisation and stability assessment of
solid lipid nanoparticles using particle size and zeta potential. J Phys Sci.
2014;25(1):59–75.
15. Chadha R, Bhandari S. Drug-excipient compatibility screening-Role of
thermoanalytical and spectroscopic techniques. J Pharm Biomed Anal. 2014;87:82–97.
16. Jain S, Patel N, Lin S. Solubility and dissolution enhancement strategies: Current
understanding and recent trends. Drug Dev Ind Pharm. 2015;41(6):875–87.
17. Xia D, Gan Y, Cui F. Application of Precipitation Methods for the Production of
Water-insoluble Drug Nanocrystals: Production Techniques and Stability of
Nanocrystals. Curr Pharm Des. 2014;20(3):408–35.
18. Bhalani D V., Nutan B, Kumar A, Singh Chandel AK. Bioavailability Enhancement
Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. Biomedicines.
2022;10(9).
19. Jadhav SP, Singh SK, Chawra HS. Review on Nanosuspension as a Novel Method for
Solubility and Bioavailability Enhancement of Poorly Soluble Drugs. Adv Pharmacol
Pharm. 2023;11(2):117–30.

20. Vinchhi P, Patel JK, Patel MM. High-pressure homogenization techniques for
nanoparticles. Emerg Technol Nanoparticle Manuf. 2021;263–85.
21. Kumar R, Dalvi S V., Siril PF. Nanoparticle-Based Drugs and Formulations: Current
Status and Emerging Applications. ACS Appl Nano Mater. 2020;3(6):4944–61.
22. Pardeshi S, More M, Patil P, Pardeshi C, Deshmukh P, Mujumdar A, et al. A
meticulous overview on drying-based (spray-, freeze-, and spray-freeze) particle
engineering approaches for pharmaceutical technologies. Dry Technol.
2021;39(11):1447–91.
23. Zhang X, Xing H, Zhao Y, Ma Z. Pharmaceutical dispersion techniques for dissolution
and bioavailability enhancement of poorly water-soluble drugs. Pharmaceutics.
2018;10(3).
24. Park H, Ha ES, Kim MS. Current status of supersaturable self-emulsifying drug
delivery systems. Pharmaceutics. 2020;12(4).
25. Trivedi NR, Rajan MG, Johnson JR, Shukla AJ. Pharmaceutical approaches to
preparing pelletized dosage forms using the extrusion-spheronization process. Crit Rev
Ther Drug Carrier Syst. 2007;24(1):1–40.
26. Soni G, Kale K, Shetty S, Gupta MK, Yadav KS. Quality by design (QbD) approach in
processing polymeric nanoparticles loading anticancer drugs by high pressure
homogenizer. Heliyon. 2020;6(4).
27. MÖSchwitzer J, Nadiem Bushrab F, MÜLler R. Manufacturing of Nanoparticles by
Milling and Homogenization Techniques. 2006;
28. Malamatari M, Somavarapu S, Taylor KMG, Buckton G. Solidification of
nanosuspensions for the production of solid oral dosage forms and inhalable dry
powders. Expert Opin Drug Deliv. 2016;13(3):435–50.
29. Mauludin R. Nanosuspensions of Poorly Soluble Drugs for Oral Administration.
2008;(December):236.
30. Peltonen L, Valo H, Kolakovic R, Laaksonen T, Hirvonen J. Electrospraying, spray
drying and related techniques for production and formulation of drug nanoparticles.
Expert Opin Drug Deliv. 2010;7(6):705–19.
31. Di Pietro P, Strano G, Zuccarello L, Satriano C. Gold and Silver Nanoparticles for
Applications in Theranostics. Curr Top Med Chem. 2016;16(27):3069–102.
32. The Road from Nanomedicine to Precision Medicine. Road from Nanomedicine to
Precis Med. 2019;
33. Regulatory and Ethical Considerations. InHandbook of Biomaterials for Medical
Applications.
34. Kardani SL. Nanocarrier-based formulations: Regulatory Challenges, Ethical and
Safety Considerations in Pharmaceuticals. Asian J Pharm. 2024;18(02).
35. GABRIELLA B, KENNETH S. A. Introduction To Cosmetic Formulation and
Technology. Wiley. 2015;725. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15003161%5Cnhttp://cid.oxfordjournals.org/loo
kup/doi/10.1093/cid/cir991%5Cnhttp://www.scielo.cl/pdf/udecada/v15n26/art06.pdf%

5Cnhttp://www.scopus.com/inward/record.url?eid=2-s2.0-
84861150233&partnerID=tZOtx3y1
36. Nanda S, Nanda A, Lohan S, Kaur R, Singh B. Nanocosmetics: Performance
enhancement and safety assurance. Nanobiomaterials Galen Formul Cosmet Appl
Nanobiomaterials. 2016;47–67.
37. Athulya R, Nandini J, Bhoi TK, Sundararaj R. Recent advances of nanotechnology in
wood protection: a comprehensive review. Wood Mater Sci Eng. 2024;19(2):279–90.
38. Mandracchia D, Tripodo G. Micro and Nano-drug Delivery Systems. Silk-based Drug
Deliv Syst. 2020;1–24.
39. Tian H, Chen J, Chen X. Nanoparticles for gene delivery. Small. 2013;9(12):2034–44.
40. Wahane A, Waghmode A, Kapphahn A, Dhuri K, Gupta A, Bahal R. Role of lipid-
based and polymer-based non-viral vectors in nucleic acid delivery for next-generation
gene therapy. Molecules. 2020;25(12).
41. Huang JG, Leshuk T, Gu FX. Emerging nanomaterials for targeting subcellular
organelles. Nano Today. 2011;6(5):478–92.
42. Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA. Targeted drug
delivery strategies for precision medicines. Nat Rev Mater. 2021;6(4):351–70.
43. McCarthy JR, Weissleder R. Multifunctional magnetic nanoparticles for targeted
imaging and therapy. Adv Drug Deliv Rev. 2008;60(11):1241–51.
44. Zhou X, Pu H, Sun DW. DNA functionalized metal and metal oxide nanoparticles:
principles and recent advances in food safety detection. Crit Rev Food Sci Nutr.
2021;61(14):2277–96.
45. Nanoparticles for Brain Drug Delivery. Nanoparticles Brain Drug Deliv. 2021;
46. Crossing the blood–brain barrier: recent advances in drug delivery to the brain.

Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 22/01/2026
Accepted 30/01/2026
Published 31/01/2026
Publication Time 9 Days
74

Login


My IP

PlumX Metrics